No/No (N = 77) |
No/Yes (N = 123) |
Yes/Yes (N = 18) |
p-value | |
---|---|---|---|---|
Patient characteristics | ||||
Average age (± SD) | 47.6 ± 16.0 | 54.5 ± 13.3 | 60.2 ± 11.6 | 0.0003 |
Gender (Female; Male) | 56; 21 | 89; 34 | 15; 3 | 0.60 |
Average Glasgow Coma Score (± SD) | 13.5 ± 3.2 | 11.8 ± 4.5 | 12.8 ± 3.4 | 0.02 |
Hunt and Hess (n, % group) | ||||
1 | 27 (35%) | 18 (15%) | 5 (28%) | 0.02 |
2 | 29 (38%) | 50 (41%) | 6 (33%) | |
3 | 11 (14%) | 19 (15%) | 5 (28%) | |
4 | 6 (8%) | 21 (17%) | 1 (5%) | |
5 | 4 (5%) | 15 (12%) | 1 (5%) | |
Comorbidities (n, % group) | ||||
Average P-POSSUM (± SD) | 22.1 ± 6.6 | 27.9 ± 8.9 | 29.9 ± 6.9 | 0.0001 |
Heart disease | 3 (4%) | 7 (6%) | 6 (33%) | 0.0001 |
Hypertension | 25 (32%) | 86 (70%) | 14 (78%) | 0.0001 |
Diabetes | 7 (9%) | 22 (18%) | 2 (11%) | 0.21 |
Dyslipidemia | 6 (8%) | 11 (9%) | 2 (11%) | 0.90 |
Previous stroke | 6 (8%) | 7 (6%) | 3 (17%) | 0.24 |
Aneurysm characteristics | ||||
Average aneurysm size (mm ±SD) | 6.3 ± 6.0 | 6.4 ± 3.4 | 7.1 ± 4.2 | 0.81 |
Aneurysm location (n, % group) | ||||
Anterior | 49 (64%) | 77 (63%) | 9 (50%) | 0.43 |
Posterior | 22 (29%) | 31 (25%) | 8 (44%) | |
Both | 6 (8%) | 15 (12%) | 1 (6%) | |
Fisher Grade (n, % group) | ||||
1 | 5 (6%) | 0 (0%) | 1 (6%) | 0.0002 |
2 | 10 (13%) | 3 (2%) | 0 (0%) | |
3 | 36 (47%) | 48 (39%) | 5 (28%) | |
4 | 26 (34%) | 72 (59%) | 12 (67%) | |
Treatment modalities (n, % group) | ||||
IV fluids for Triple-H therapy | 53 (69%) | 102 (83%) | 15 (83%) | 0.05 |
Vasopressors and/or Inotropes | 19 (25%) | 23 (19%) | 3 (17%) | 0.54 |
Ventricular drainage | 45 (58%) | 97 (79%) | 13 (72%) | 0.008 |
Angioplasty/local CCB infusion | 14 (18%) | 14 (11%) | 3 (17%) | 0.38 |
Clipped/Coiled (n, % group) | ||||
Clipped | 52 (68%) | 72 (60%) | 11 (61%) | 0.65 |
Coiled | 23 (30%) | 46 (38%) | 6 (33%) | |
Both | 2 (3%) | 2 (2%) | 1 (6%) | |
Cerebral performace category (n, % group) | ||||
1-2 (optimal) | 61 (84%) | 79 (70%) | 10 (59%) | 0.04 |
3-5 (poor) | 12 (16%) | 34 (30%) | 7 (41%) |